ENHANCING ONCOLOGY INVESTIGATE WITH BUILT-IN KRAS ASSAY PROVIDERS AND RAS ASSAYS

during the fast evolving area of oncology research, correct and effective mutation screening is vital for developing specific therapies. The KRAS providers Platform plays a pivotal purpose On this landscape by giving extensive remedies for KRAS mutation profiling and Assessment. KRAS mutations, located in close to 95% of RAS-related oncogenic alter